Accessibility Menu

Aspira Women's Health

(OTC) AWHL

Current Price$0.35
Market Cap$15.22M
Since IPO (2000)-100%
5 Year-100%
1 Year-90%
1 Month-8%

Aspira Women's Health Financials at a Glance

Market Cap

$15.22M

Revenue (TTM)

$9.34

Net Income (TTM)

$10.80

EPS (TTM)

$-0.38

P/E Ratio

-0.93

Dividend

$0.00

Beta (Volatility)

0.29 (Low)

Price

$0.35

Volume

1,454

Open

$0.35

Previous Close

$0.35

Daily Range

$0.35 - $0.35

52-Week Range

$0.02 - $0.71

AWHL News

No articles available.

AWHL: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aspira Women's Health

Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.

Industry

Healthcare Equipment and Supplies

Employees

66

CEO

Michael Buhle

AWHL Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-1.08%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

$15.22M

Shares Outstanding

43.48M

Volume

1.45K

Short Interest

0.00%

Avg. Volume

70.67K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Aspira Women's Health Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q3 2025YOY CHG

Revenue

$2.31

+1.0%

Gross Profit

$1.38

+1.0%

Gross Margin

60.00%

+1.0%

Market Cap

$15.22M

N/A

Market Cap/Employee

$0.26

N/A

Employees

66

N/A

Net Income

$4.89

+1.4%

EBITDA

$1.53

+0.4%

Quarterly Fundamentals

Name
Q3 2025YOY CHG

Net Cash

$3.81

+1.8%

Accounts Receivable

$1.32

+1.1%

Inventory

$0.28

+1.0%

Long Term Debt

$2.16

+1.3%

Short Term Debt

$0.42

+1.0%

Return on Assets

-179.16%

+0.8%

Return on Invested Capital

7626.27%

+14.7%

Free Cash Flow

$0.22

+0.1%

Operating Cash Flow

$0.21

+0.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$6716.09+0.00%
^DJIDJI
$46993.26+0.00%
^IXICNASDAQ
$22479.53+0.00%
BTCBitcoin
$74342.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDANvidia
$181.19-0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$46.45-0.04%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.16+0.01%
AALAmerican Airlines Group
$10.83-0.00%

Questions About AWHL

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.